What's Trending

Assessing Risks and Impacts of AI (ARIA) is a research program by the National Institute of Standards and Technology (NIST) aimed at...

Following Trump's victory, a surge in confidence in the United States economy has been noted by some investors. This sentiment was echoed...

On Dec. 8, the European Union (EU) updated its Product Liability Directive (PLD) to, inter alia, specifically address AI software. This...

The U.S. Patent and Trademark Office (USPTO) has implemented three new rules impacting practice before the Patent Trial and Appeal Board...

U.S. Patent and Trademark Office Director Kathi Vidal announced her departure from the agency to return to the private sector, a move...

As required under the October 30, 2023, Executive Order 14110 on the Safe, Secure, and Trustworthy Development and Use of Artificial...

The U.S. Patent and Trademark Office director, Kathi Vidal, released a final rule on Director Review effective October 31, which expands...

The United States Patent and Trademark Office (USPTO) has announced new rules governing amendment practice in trial proceedings under the...

In patent litigation, expert witnesses play a crucial role in providing specialized knowledge to the court. In a recent case where Osseo...

The recent case involving United Therapeutics' patent on Tyvaso and Liquidia's Yutrepia sheds light on the complexities of patent law....

Recent cases show the U.S. Patent and Trademark Office director's interest in using director review to address substantive issues like...

The Court of Appeals for the Federal Circuit has sparked debate following a recent ruling on the Patent Trial and Appeal Board's (PTAB)...